Login
$SUNS
$6.46 +$0.11 (1.73%) Close

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Assets
Loan receivable held at carrying value, net
Loans held for investment at carrying value, net
Current expected credit loss reserve
Loans held for investment at carrying value, net of current expected credit loss reserve
Cash and cash equivalents
Interest receivable
Investment in unconsolidated real estate joint venture
Prepaid expenses and other assets
Total assets
Liabilities
Due to affiliate
Accrued interest
Dividends payable
Current expected credit loss reserve
Accrued management and incentive fees
Accrued direct administrative expenses
Accounts payable and other liabilities
Line of credit payable
Nonrelated Party
Related Party
Total line of credit payable
Total liabilities
Shareholders' equity
Preferred stock, par value $0.01 per share, 10,000 shares authorized at June 30, 2026 and December 31, 2025 and 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock, par value $0.01 per share, 50,000,000 shares authorized at June 30, 2026 and December 31, 2025 and 13,517,402 and 13,420,986 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated (deficit) earnings
Total shareholders' equity
Total liabilities and shareholders' equity
Preferred stock, authorized (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support